GNRH1 and adenomyosis: Gonadotropin-releasing hormone (GnRH) analogs (both agonists and antagonists) are pivotal in managing adenomyosis due to their ability to downregulate gonadotropin release, leading to reduced estrogen levels and subsequent shrinkage of the uterus, alleviating associated pain [49].